Question
Is Bifidobacterium longum (and B. infantis / B. lactis) legit?
In context of Bifidobacterium longum (and B. infantis / B. lactis)·Mixed evidence66/100
In our editorial model, Bifidobacterium longum (and B. infantis / B. lactis) maps to a Mixed evidence verdict at 66/100 overall (evidence 62/100, safety 74/100, hype gap 52/100). IBS-C adjunct (B. infantis 35624 studied); Infant microbiome; Constipation marketing. Typical label framing: Multi-billion CFU products; strain identity matters.
Full ingredient file
This page is a short answer. Mechanisms, dosing notes, sources, and the rest of the verdict live on the hub for Bifidobacterium longum (and B. infantis / B. lactis).
Open Bifidobacterium longum (and B. infantis / B. lactis) verdictOther questions on Bifidobacterium longum (and B. infantis / B. lactis)
A few more focused pages for the same ingredient (we keep lists short on purpose).
← Bifidobacterium longum (and B. infantis / B. lactis) hubBrowse categories